Anna Maria Di GiacomoUniversity of Siena and Center for Immuno-Oncology, University Hospital of Siena, Siena, ItalyMark VoskoboynikAlfred Health, Melbourne, AustraliaNicole MyerMerck & Co., Inc., Rahway, NJMackenzie EdmondsonMerck & Co., Inc., Rahway, NJQi Liu...
Daniel John RenoufCancer - Vancouver, Vancouver, BC, CanadaQi LiuMerck & Co., Inc., Rahway, NJMackenzie EdmondsonMerck & Co., Inc., Rahway, NJNicole MyerMerck & Co., Inc., Rahway, NJAmerican Society of Clinical OncologyJournal of Clinical Oncology...
Acknowledgements Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA provided drug and financial support for the study. Trial Registration Clinical Trial Registry Number: NCT04541108 References Klinghoffer RA, Bahrami SB, Hatton BA, Frazier JP, Moreno-Gonzalez A, ...
Ding WangMerck & Co., Inc., Kenilworth, NJ and Henry Ford Hospital, Detroit, MI;Talia GolanSheba Medical Center, Tel Aviv University, Ramat Gan, Israel;Daniel RenoufCancer; University of British Columbia, Vancouver, BC, Canada;Mark Voskoboynik...